. .

:

. . *,
. . **,
. . ***
. . *,
. . *,
. . *
* ,
** ,
*** 40,

. (), (World Gastroenterology Organisation, WGO) 2009 ., , / [1].

2,9% 22%, -, [13].

, 50 . , . [1].

, , [3]. , , , .

, . , , .

, , . [4, 5]. [3]. , , . (), [6, 7].

PYY, , , , [810]. (GPR41, GPR43, 5-HT-4). , , 3- . , , [9, 1115].

, , , . , (5-), YY- [16, 17].

III 2006 . [4], : ; . : (< 3 > 3 ); / / ; ; , .

, III, :

1) (IBS-C);
2) (IBS-D);
3) (IBS-M);
4) (IBS-U).

, , , ʻ (IBS-A).

, (, 2009): (-); , ; , .

, , .

: , , ( , ACT, , , γ-, , ), , . , . : , , , , .

, ( ), , .

, III, . , , , , . , (, , ).

, , 15.06.15 . . (www.gastro.ru). 774 09.11.2012 . 1420 24.12.2012 .

, , , , . .

, , , , () () .

: , 18 50 , . : - , , , , 3 .

. 1- () 35 (24 11 ), 4 () 200 3 . 2- () 35 (24 11 ), 28 200 3 () 1 . 3 . 1- 39,5 (33,0 49,0) , 2- 38,0 (32,0 49,0) . 1- 31 , 2- 34 . .

, , . :

1. , .
2. , 7- - .
3. , 7- - .
4. , .
5. , .
6. , ( 0 100).

Statistica 6.0. (W). W- ( < 0,05), . () 25- 75- (25 75). < 0,05.

, , , 17,0 (13,0 18,0) , 10,0 (4,0 16,0) 11,0 (5,0 17,0) . 3,4 (1,9 4,0) , 2,0 (0,6 2,0) . ( < 0,01). 53% (17 63).

, , 13,5 (8,0 15,0) , 5,0 (3,0 14,0) 9,0 (7,0 14,0) . 3,0 (2,6 3,1) , 0,55 (0,3 1,0) . ( < 0,01). 67% (57 72).

, ( < 0,03) (. 1). , , ( < 0,01) (. 2). , . , , ( = 0,047). . , , .

( 200 3 ) . ( 200 3 () 1 . 3 ) , .

, , . , ().

( ) .

1. www.worldgastroenterology.com/guideline-ibs/irritable-bowel-sindrome-ibs-russian.
2. Longstreth G. F., Wilson A., Knight K. et al. Irritable bowel syndrome, health care use, and costs: a U. S. managed care perspective // Am J Gastroenterol. 2003; 98: 600607.
3. www.worldgastroenterology.com/guideline-ibs/irritable-bowel-sindrome-ibs-english.
4. Drossman D. A. The Functional Gastrointestinal Disorders and the Rome III Process // Gastroenterology. 2006; 130 (5): 13771390.
5. Lembo T., Naliboff B., Munakata J. et. al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome // Am J Gastroenterol. 1999; 94: 13201326.
6. Cummings J. Y., Rombeau J. L., Sakata T. (eds). Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge University Press. 2004. 596 p.
7. Hu S., Dong T. S., Dalai S. R., Wu F., Bissonnette M., Rwon J. H. et al. The microbe derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer // PLoS ONE. 2011; 6 (1): 16221.
8. Cherbut C. Lactulose and colonic motility // Annales de Gastroenterologie et dHepatologie. 1998; 34 (2): 8594.
9. Cherbut C., Aube A. C., Blottiere H. M., Galmiche J. P. Effects of short-chain fatty acids on gastrointestinal motility // Scand. J. Gastroenterology. 1997; 32 (Supp. 222): 5861.
10. Nieuwenhuijs V. B., Verheem A., Van Duijvenbode-Beumer H. et al. The role of interdigestive small bowel motility in the regulation of gut micro? ora, bacterial overgrowth, and bacterial translocation in rats // Annals of Surgery. 1998; 228 (2): 188193.
11. . . : []. .: . 2014. . 64.
12. Canani R. B., Di Costanzo M., Leone L., Pedata M., Meli R., Calignano A. Potential benecial effects of butyrate in intestinal and extraintestinal diseases // World J Gastroenterol. 2011; 17 (12): 15191528.
13. MacFabe D. F. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders // Microb Ecol. Health Dis. 2012; 23. DOI: 10.3402/mehd.v23 i0.19260.
14. Soret R., Chevalier J., De Coppet P. et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats // Gastroenterology. 2010; 138 (5): 17721782.
15. Tazoe H., Otomo Y., Kaji I. et al. Roles of short-chain fatty acids receptors GPR41 and GPR43 on colonic functions // J Physiol Pharmacol. 2008; 59 (Suppl 2.): 251262.
16. Kilkens T. O., Honig A., van Nieuwenhoven M. A., Riedel W. J., Brummer R. J. Acute tryptophan depletion affects braingut responses in irritable bowel syndrome patients and controls // Gut. 2004; 53 (12): 17941800.
17. Vahoutvin S. A., Troost F. J., Kilkens T. O. et al. The effects of butyrate enemas on visceral perception in healthy volunteers // Neurogastroenterol Motil. 2009; 21 (9): 952-e76.